MetLife Investment Management’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-18,852
| Closed | -$104K | – | 2933 |
|
|
2022
Q1 | $104K | Buy |
18,852
+2,096
| +13% | +$11.5K | ﹤0.01% | 2617 |
|
|
2021
Q4 | $162K | Hold |
16,756
| – | – | ﹤0.01% | 2183 |
|
|
2021
Q3 | $300K | Hold |
16,756
| – | – | ﹤0.01% | 1822 |
|
|
2021
Q2 | $409K | Buy |
16,756
+2,464
| +17% | +$60.1K | ﹤0.01% | 1694 |
|
|
2021
Q1 | $379K | Buy |
+14,292
| New | +$379K | ﹤0.01% | 1680 |
|
|
2020
Q3 | – | Sell |
-17,589
| Closed | -$105K | – | 2346 |
|
|
2020
Q2 | $105K | Buy |
+17,589
| New | +$105K | ﹤0.01% | 2233 |
|
|
2020
Q1 | – | Sell |
-16,410
| Closed | -$156K | – | 2321 |
|
|
2019
Q4 | $156K | Hold |
16,410
| – | – | ﹤0.01% | 2113 |
|
|
2019
Q3 | $129K | Hold |
16,410
| – | – | ﹤0.01% | 2194 |
|
|
2019
Q2 | $258K | Hold |
16,410
| – | – | ﹤0.01% | 1881 |
|
|
2019
Q1 | $297K | Buy |
16,410
+5,629
| +52% | +$102K | ﹤0.01% | 1758 |
|
|
2018
Q4 | $173K | Hold |
10,781
| – | – | ﹤0.01% | 1985 |
|
|
2018
Q3 | $259K | Buy |
+10,781
| New | +$259K | ﹤0.01% | 1944 |
|